Aberdeen Asset Management plc Rating Reiterated by Barclays (ADN)
Aberdeen Asset Management plc (LON:ADN)‘s stock had its “overweight” rating reiterated by investment analysts at Barclays in a note issued to investors on Friday, American Banking News reports. They currently have a GBX 500 ($8.09) price objective on the stock. Barclays’ price objective would indicate a potential upside of 8.91% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at RBC Capital reiterated an “outperform” rating on shares of Aberdeen Asset Management plc in a research note to investors on Thursday. They now have a GBX 480 ($7.76) price target on the stock. Separately, analysts at Shore Capital Stockbrokers reiterated a “buy” rating on shares of Aberdeen Asset Management plc in a research note to investors on Thursday. Finally, analysts at UBS AG reiterated a “neutral” rating on shares of Aberdeen Asset Management plc in a research note to investors on Wednesday. They now have a GBX 404 ($6.53) price target on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of GBX 468.78 ($7.58).
Aberdeen Asset Management plc (LON:ADN) traded up 1.93% during mid-day trading on Friday, hitting GBX 459.10. 5,263,888 shares of the company’s stock traded hands. Aberdeen Asset Management plc has a one year low of GBX 317.80 and a one year high of GBX 492.20. The stock’s 50-day moving average is GBX 381.1 and its 200-day moving average is GBX 405.2. The company’s market cap is £5.220 billion.
Aberdeen Asset Management PLC is an international asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.